[1] M.Brownlee H, Vlassara A, Kooney, et al. Aminoguanidine prevents diabete-induced arterial wall protein cross-linking [J]. Science, 1986, 232(4758)∶1629-1632 [2] Enomoto M, Adachi H, Yamagishi S, et al. Positive association of serum levels of advanced glycation end products with thrombogenic makers in humans [J]. Metabolism, 2006, 55∶912-917 [3] Loe H, Periodontal disease. The sixth complication of diabetes mellitus [J]. Diabetes Care, 1993, 16(1)∶329-334 [4] Covani U, Marconcini S, Derchi G, et al. Relationship between human periodontitis and type2 diabetes at a genomic level:a data-mining study [J]. J Periodontol,2009,80(8)∶1265-1273 [5] Wu X-D, Liu W-L, Zeng K, et al. Advanced glycation end products activate the miRNA/RhoA/ROCK2 pathway in endothelial cells [J]. Microcirculation, 2014, 21∶178-186 [6] Morita M,Yano S,Yamaguchi T, et al. Advanced glycation end products induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells [J]. J Diabetes Complications, 2013, 27∶11-15 [7] Kang R, Tang D, Schapiro NE, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival [J]. Cell Death Differ, 2010, 17∶666-676 [8] Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis [J]. Mol Cell Biochem, 2012, 359∶73-81 [9] Santel A,Fuller MT,Control of mitochondrial morphology by a human mitofusin [J]. J Cell Sci,2001,114(5)∶867-874 [10] Chen KH, Guo XM, Dalong MA, et al. Dysregulation of HSG triggers vascular proliferative disorders [J]. Nature Cell Biol,2004,6(9)∶872-883 [11] Zhang Y, DU Q, Qiu XY, et al. Over expression of hyperplasia suppressor gene inhibits the malignant phenotype of breast cancer cell [J]. Zhonghua Bing Li Xue Za Zhi, 2010, 39(4)∶259-263 |